Swaminathan Arun
SEC insider (Form 3/4/5 filer). CIK 0002034346. Chief Executive Officer at Coya Therapeutics, Inc. (COYA). 4 reported Form 4/5 transactions since Sep 2024; latest on Jan 22, 2026. Located in HOUSTON, TX.
Companies Swaminathan Arun has filed insider reports for
- Coya Therapeutics, Inc. (COYA): Director, Officer, Chief Executive Officer
Swaminathan Arun
CIK: 0002034346
Transaction Breakdown
Open Market Buys (P)2 (50.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
COYA
Coya Therapeutics, Inc.
DirectorOfficer
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jan 22, 2026COYA
Coya Therapeutics, Inc.
AwardDirectStock Option (right to buy)
294K shares- - Jan 9, 2025COYA
Coya Therapeutics, Inc.
AwardDirectStock Option (right to buy)
241K shares- - Nov 13, 2024COYA
Coya Therapeutics, Inc.
PurchaseDirect5K shares at avg. $7.36$37K - Nov 11, 2024COYA
Coya Therapeutics, Inc.
PurchaseDirect5K shares at avg. $7.34$37K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 22, 2026 | COYA Coya Therapeutics, Inc. | Award Stock Option (right to buy) | 293,983 | - | - | Direct |
| Jan 9, 2025 | COYA Coya Therapeutics, Inc. | Award Stock Option (right to buy) | 240,964 | - | - | Direct |
| Nov 13, 2024 | COYA Coya Therapeutics, Inc. | Purchase | 5,000 | $7.36 | $36,797 | Direct |
| Nov 11, 2024 | COYA Coya Therapeutics, Inc. | Purchase | 5,000 | $7.34 | $36,689 | Direct |
1-4 of 4 transactions